Resolve M Therapeutics exits from stealth
Unique platform designed to engage pro-resolution responses to restore immune homeostasis in inflammatory disorders without broad immuno-suppression. Resolve M Therapeutics, Inc., the biotech aiming to build the world's first comprehensive pro-resolution platform for target ID, validation and drug discovery for the treatment of inflammatory diseases, has announced its exit from stealth. Resolve M was created […]